aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Cambridge, Massachusetts, Scholar Rock Holding Corporation is a biopharmaceutical company dedicated to discovering and developing innovative treatments for neuromuscular disorders, cancer, fibrosis, and anemia. The company's core mission is to unlock fundamentally different therapeutic approaches through bold science and a unique drug discovery platform. Scholar Rock's products and services focus on advancing the standard of care by targeting protein growth factors that are fundamental to disease progression.
Notable affiliated people include leading scientists and industry experts who contribute to Scholar Rock's pioneering research. The company has attracted significant investment from top-tier venture capital firms, fueling its growth and innovation. Key achievements include the development of a robust pipeline of potential therapies that have shown promise in preclinical and clinical trials. Scholar Rock's impact lies in its potential to transform treatment paradigms and improve outcomes for patients with serious diseases.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Biopharmaceuticals
Technology
Biotech
Tags
Biotech, Healthtech
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Scholar Rock Holding founded?
Scholar Rock Holding was founded in 2017.
Where is Scholar Rock Holding’s headquarters located?
Scholar Rock Holding’s headquarters is located in Cambridge, MA, US.
How many employees does Scholar Rock Holding have?
Scholar Rock Holding has 114 employees as of Feb 6, 2024.
Add Comparison
Total Employees Over Time
114
As of Feb 2024
Scholar Rock Holding Address
301 Binney Street
3rd Floor
Cambridge,
Massachusetts
02142
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts